Nutraceutical OEM Contracts: Quality Liability, Recall Mechanics and Indemnity Clauses
In most projects the contract is the section people turn fastest: once price, lead time and payment terms are agreed, the clauses get copied from a template. Yet when a quality dispute arises, it is exactly those skipped pages that decide the outcome. Health products carry food-safety exposure, so a single incident can generate losses across the goods themselves, recall and destruction costs, channel penalties, administrative fines, brand damage and consumer compensation - and how all of that is allocated between brand owner and manufacturer depends entirely on what the contract says. In contract manufacturing across formats such as pressed candy we prefer to negotiate the clauses in detail, not to deflect responsibility but because projects with clear boundaries generate the fewest disputes in practice.
1. Decide who defines the standard
Nearly every quality dispute reduces to one question: did the product meet the agreed standard. So the most important clause is not a vague reference to national standards but a specific, versioned source. Three items belong in it. The applicable standard number and version, covering both the product standard and any relevant limits. An internal specification or mutually signed spec sheet listing key parameters, test methods and decision rules, attached as a contract annex. And a change mechanism describing how a new standard is adopted when regulations or customer requirements move, and who absorbs the resulting cost and obsolete stock. That third item is the one most often missed, and it is the one that causes stalemates when old packaging and inventory become unusable. Define the standard well and half the liability question answers itself.
2. How liability is actually split
The governing principle is that whoever controls a stage carries it. On raw materials: if the defect originates in material the manufacturer purchased or in its supplier controls, the manufacturer owns it; if the brand nominated or supplied the material, responsibility shifts - but the manufacturer retains an incoming inspection duty, and that must be stated, otherwise "customer-nominated supplier" becomes a hole through which unlimited exposure disappears. Production - process control, environmental monitoring, changeover, batch records - sits with the manufacturer. Storage and transport follow the delivery term that marks the transfer of risk. Design needs separating out: whether the formulation was developed by the manufacturer or supplied by the brand, and if the brand supplied a non-compliant formula or claim requirement, the manufacturer has a duty to review and flag it while retaining the right to refuse to proceed.
3. Writing a recall clause that works
Recall is the highest-loss event category and deserves its own clause. Four layers are needed. Triggers: define what starts a recall - a failed safety parameter, a regulatory notification, a cluster of adverse reaction reports - so that whether something counts as a recall is not itself disputed. Decision and execution: the brand owner, as the marketing authorisation or filing holder, normally communicates externally, while the manufacturer supplies batch data, retained samples and investigation support. Cost allocation: follows liability, and where liability is not yet established, provide for interim advance payment and proportional sharing after investigation. Notification deadline: how many hours either party has to inform the other after learning of a risk, which is the single most effective control on how large the loss becomes. Without a deadline, escalation is hard to attribute.
4. Indemnity caps and exclusions
Indemnity is where negotiations usually stall. Manufacturers want a cap, commonly the value of the batch or of the contract year. Brand owners worry a cap will not cover recall and brand damage. A layered structure tends to resolve it: ordinary quality issues - a parameter out of specification with no safety implication - capped at the goods value; major safety and compliance failures attributable to the manufacturer, such as a mandatory recall or administrative penalty, carrying a higher cap or none, but limited to direct losses. Exclusions must also be stated: whether indirect losses, lost profit and goodwill fall inside the indemnity. Positions differ sharply here, but clarity beats argument later. Product liability insurance is a useful companion, materially reducing extreme exposure on both sides.
5. Making IP and confidentiality operative
Formula ownership and confidentiality generate frequent disputes and need to distinguish three cases. A brand-supplied formula: ownership stays with the brand, the manufacturer uses it only to fulfil orders during the term. A manufacturer-developed formula: either bought out by the brand, licensed exclusively, or co-owned with a defined field of use. Joint development: ownership shares and use boundaries agreed at project start. Confidentiality clauses must be specific - scope of confidential information, duration, typically extending several years past termination, who may access it, and consequences of breach. A clause that says only "confidential" rarely constrains anyone in practice. One prohibition should be explicit: the manufacturer may not use a customer's formula to produce for anyone else.
6. Clauses that get missed
Beyond the core items, several omissions cause real damage. Retention and traceability period: how long samples are kept and what happens at expiry, which determines whether evidence exists when a dispute arises. Audit rights: whether the brand may audit the site, at what frequency and with what notice. Subcontracting limits: whether any process step may be outsourced and whether the subcontractor needs approval. Transition on termination: what happens to inventory, tooling, packaging and formulation documentation. And governing law and dispute resolution. These look redundant while things run smoothly, but together they decide whether a problem gets resolved against an agreed rulebook or dissolves into a long argument. Detailed contracts tend to produce longer relationships, not shorter ones.
Related Products
Glycerol diester coffee OEM OEM OEM OEM OEM meal replacement coffee MCT live broadcast same solid beverage source manufacturer | GLP-1 Semaglutide Satiety & Fat Blocker Tablets | Custom Pressed Candy OEM Manufacturing
About Guangzhou Mesen Health Biotechnology Co., Ltd
Guangzhou Mesen Health Biotechnology Co., Ltd is located in the Huashan Science and Technology Park, Huadu District, Guangzhou. The company has focused on OEM and ODM services for the big health industry for nearly 20 years, operating dedicated research, production, sales and management centres, and maintaining long-term strategic partnerships with well-known Chinese medicine colleges and research institutions. Capabilities span pressed candy, gummies, capsules, solid beverages, herbal teas, plant beverages, protein powders, dietary supplements and enzyme jelly - from formulation development through contract manufacturing. For details on minimum order quantities, sampling lead times and quotations, see our manufacturing advantages and product range, or contact us for a tailored proposal.
Further Reading
